A naukri.com initiative
Unite
1w
175
Image Credit: Unite
Joseph Mossel, Co-Founder & CEO of Ibex Medical Analytics – Interview Series
- Joseph Mossel is the CEO of Ibex Medical Analytics, with over 20 years of experience in the tech industry.
- Ibex, founded by Mossel, offers a platform to detect and grade cancers across various tissues using AI.
- The platform aids pathologists in accurate diagnostics and improving patient outcomes.
- Mossel's background in computer science and environmental science led to his work in AI-powered pathology.
- Challenges faced by Ibex included data access, capital, and domain-specific knowledge, which were overcome through partnerships.
- FDA clearance for Ibex Prostate Detect signifies a milestone in improving diagnostic accuracy and patient outcomes.
- The approval highlights missed cancer diagnoses, showcasing the potential of AI in enhancing diagnostic precision.
- Ibex Prostate Detect's unique heatmap feature assists pathologists in identifying cancerous tissue accurately.
- The AI model was trained by world-renowned pathologists, ensuring high accuracy in different patient demographics.
- Ibex focuses on expanding diagnostic capabilities for breast, gastric, and other cancers, with a special focus on AI advancements.
- In the next five to ten years, AI-powered pathology is expected to transform cancer diagnostics, improve workflow efficiency, and enhance health equity.
Read Full Article
10 Likes
For uninterrupted reading, download the app